SCHEMBL20845239

SCHEMBL20845239

C1=C\c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2-c2ccccc2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.42
▸ KMT2A Q03164 10/20 0.42
▸ HPGD P15428 8/20 0.42
▸ MAPT P10636 8/20 0.42
▸ ALDH1A1 P00352 7/20 0.42
▸ NTSR1 P30989 1/20 0.42
▸ KDM4E B2RXH2 5/20 0.40
▸ LMNA P02545 3/20 0.40
▸ GLA P06280 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ ADORA2A P29274 2/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ CYP2C19 P33261 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ AGTR1 P30556 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845138 0.96 MEN1 (0.44) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845141 0.92 MEN1 (0.37) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845241 0.92 MEN1 (0.39) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845246 0.91 CYP19A1 (0.43) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845325 0.90 MEN1 (0.36) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845328 0.90 MEN1 (0.40) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845330 0.90 CYP19A1 (0.42) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845319 0.88 GP6 (0.33) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845322 0.87 MEN1 (0.34) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL20845323 0.87 MEN1 (0.34) MEN1KMT2AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 MEN1 3151/4885KMT2A 880/4885HPGD 4313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback